Related Experiment Video
Updated: Jan 5, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Nevirapine inhibits migration and invasion in dedifferentiated thyroid cancer cells
Hongxia Shang1, Junyu Zhao1,2, Jinming Yao1,2
1Division of Endocrinology, Department of Internal Medicine, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.
Background:
Metastatic or recurrent thyroid cancer often behaves aggressively, and approximately two-thirds of patients present with radioiodine resistance. Effective therapies to suppress thyroid cancer metastasis are urgently needed. Nevirapine has been proved to suppress tumor growth and induce differentiation in several tumor cells, but has not previously been evaluated in metastasis of thyroid cancer. The present study aimed to investigate the effect of nevirapine on migration and invasion in dedifferentiated thyroid cancer cells.
Methods:
Human dedifferentiated thyroid cancer cell line (WRO 82-1) was subject to real-time quantitative PCR, western blot and transwell migration/invasion assays. The liver metastasis in tumor xenografts of nude mice was subject to hematoxylin-eosin (HE) staining.
Results:
Nevirapine significantly repressed cell migration and invasion in WRO 82-1 cells, and surprisingly significantly decreased liver metastatic tumor in the nude mouse model of dedifferentiated thyroid cancer compared with that of the control. Moreover, nevirapine significantly decreased the expression of IL-6 mRNA and phosphorylation of JAK2 (Y1007+Y1008) and STAT3 (Tyr 705) in WRO 82-1 cells compared with those in control cells.
Conclusion:
Our findings suggest that nevirapine significantly repressed migration and invasion/metastasis in WRO 82-1 cells and tumor xenografts, which may be related to inhibition of IL-6/STAT3 signaling pathway. It promises great potential as a novel therapy for thyroid cancer, especially for those patients with metastasis.
Insights
Nevirapine effectively suppresses thyroid cancer metastasis by inhibiting cell migration and invasion. This novel therapy shows promise for treating aggressive thyroid cancers, particularly those that have spread.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Thyroid cancer metastasis is aggressive and often radioiodine resistant.
- Current therapies for metastatic thyroid cancer are limited.
- Nevirapine's anti-cancer effects are known, but its role in thyroid cancer metastasis was unexplored.
Purpose of the Study:
- To investigate the efficacy of nevirapine in suppressing migration and invasion of dedifferentiated thyroid cancer cells.
- To evaluate nevirapine's impact on thyroid cancer liver metastasis in a preclinical model.
Main Methods:
- Utilized WRO 82-1 dedifferentiated thyroid cancer cell line.
- Performed real-time quantitative PCR, western blot, and transwell migration/invasion assays.
- Assessed liver metastasis in nude mouse xenografts using hematoxylin-eosin staining.
Main Results:
- Nevirapine significantly reduced migration and invasion in WRO 82-1 cells.
- Nevirapine markedly decreased liver metastasis in a mouse model.
- Observed decreased IL-6 mRNA expression and reduced JAK2/STAT3 pathway activation.
Conclusions:
- Nevirapine inhibits thyroid cancer cell migration, invasion, and metastasis.
- The mechanism involves the downregulation of the IL-6/STAT3 signaling pathway.
- Nevirapine presents potential as a novel therapeutic agent for metastatic thyroid cancer.
More Related Videos
11:00Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection
Published on: June 23, 2023
06:08Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Published on: June 2, 2023
Related Concept Videos
Cancer Cell Migration through Invadopodia
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mechanisms of Retrovirus-induced Cancers